Introduction
Spirocyclic compounds have been increasingly exploited as lead compounds in the early phases of drug discovery due to their unique properties, such as intrinsic three-dimensionality, conformational restriction enhancing binding to a target and structural patentability.
[1] Over the past few years, various examples of natural compounds and synthetic drugs containing spiro-fused heterocycles have been discovered to possess relevant biological activities (Figure 1) . [2] In particular, nitrogen-containing spiro heterocycles have been identified as playing key roles in biological and pharmaceutical processes, [3] rendering this framework an attractive building block for further research. Examples include iboluteine, an iboga-type indole alkaloid isolated from the Apocynaceae family, fluspirilene, an antipsychotic drug used for the treatment of schizophrenia, and fenspiride hydrochloride, an antitussive drug. clization after condensation of several tryptamine derivatives with three novel piperidin-4-ones containing the fluorinated substituents F, CF 3 and SF 5 . The piperidin-4-ones were synthesized from readily available starting materials by an enantioselective multi-component organocatalytic Mannich reaction.
In this regard, substituents at the 2-and 6-positions of the piperidine ring could be vital to modulate biological activity. [4] Furthermore, it is well documented that the presence of fluorine atoms can greatly enhance the drug-likeness of small molecules. As a result of properties such as electronegativity, atom size and lipophilicity, the introduction of fluorine into small molecules can effectively alter their biological activity and bioavailability in comparison with their non-fluorinated counterparts. [5, 6] Inspired by previous piperidinone syntheses by our group, [7] and in conjunction with current work on spirocyclic compound libraries within the framework of the European Lead Factory, [8] we herewith report an enantio-and diastereoselective reaction sequence for the synthesis of spiro [2,6-diarylpiperidinepyridoindole] structures 7 and their utilization in the synthesis of a focused compound library also containing a variety of fluorine functionalities.
Results and Discussion
From a retrosynthetic point of view, the spiro[piperidinepyridoindole] core of compounds 7 can be generated from piperidin-4-one 4 and substituted indole derivatives through a diastereoselective Pictet-Spengler reaction (Scheme 1). The enantiopure piperidin-4-one 4 can itself be diastereoselectively obtained from -amino ketone 3 by an intramolecular organocatalysed Mannich reaction. Lastly, amino ketone 3 should be accessible through an enantioselective organocatalysed threecomponent Mannich reaction with commercially available p-anisidine, 3,4-dimethoxybenzaldehyde and acetone.
The forward synthesis commenced with the preparation of protected -amino ketone 1, as previously reported by our group. [7] Compound 1 was obtained in 61 % yield and >99 % ee through a multi-component L-proline-catalysed Mannich reaction. [7, 9] We selected compound 1 for the synthesis of this Scheme 1. Retrosynthesis of the spiro[piperidine-4,1′-pyrido [3,4-b] indole] framework.
library due to the high relevance of the 3,4-dimethoxyphenyl group in nature and active drugs. [10] From compound 1, two possible synthetic routes for the synthesis of 2,6-disubstituted piperidin-4-ones were envisioned (Scheme 2). Early efforts were focused on the synthesis of p-methoxyphenyl (PMP) protected piperidinones 2 in a one-pot procedure by a Mannich cyclization. This approach involved the synthesis of the scaffold, which proved a challenge owing to the high level of steric hindrance arising from the three contiguous substituents.
[11] In our efforts to synthesize product 2, protected amine 1 was treated with several aldehydes in the presence of various catalysts and under a range of temperatures (see the Supporting Information). Unfortunately, none of these conditions led to the desired N-protected piperidin-4-one 2. Owing to these difficulties, we then chose to synthesize the unprotected scaffold 4 with reduced steric hindrance (Scheme 2). To this end, the N-PMP amine 1 was deprotected by employing H 5 IO 6 under acidic conditions to afford the corresponding product 3 in 46 % yield. [12] Subsequently, the free amino ketone 3 was treated with triethylamine and 4-fluorobenzaldehyde to afford imine 5 (R = F). 1 H NMR analysis of the reaction mixture showed not only imine formation, but also the presence of a side-product, which could not be characterized, and the cyclized product 4A. Several reaction conditions were investigated to achieve the full conversion of imine 5 into the desired product 4A (Table 1) . The conditions previously reported by us [7] for these types of cyclizations were unsuccessful (Table 1 , Entry 4). After further investigation, we found that full conversion to the cyclized product 4A could be achieved when using L-proline as the catalyst (Table 1 , Entry 6). In addition, 1 H NMR analysis of the reaction mixtures showed the existence of a slow equilibrium between imine 5 and cyclized product 4A under certain conditions, which led to different ratios of products depending on the temperature. In this manner, we observed that at low temperatures the formation of 4A was favoured, whereas at room temperature imines 5 and 6 were the major compounds in the reaction mixture. The presence of 5 and 6, 4-fluorobenzaldehyde and 3,4-dimethoxybenzaldehyde confirmed the existence of an equilibrium between compounds 4A, 5 and 6 (Scheme 3). Following the optimization of the two-step synthesis of 4A, a one-pot procedure for the preparation of the cyclized product directly from 3 was investigated. Thus, amine hydrochloride 3 was treated with Et 3 N and anhydrous Na 2 SO 4 in the presence of catalytic amounts of L-proline to afford the cyclized product 4A in 75 % yield. In the same way, two additional cis-2,6-diarylpiperidin-4-ones, 4B and 4C containing CF 3 and SF 5 groups, were synthesized in yields of 38 and 28 %, respectively (Scheme 2). [13] The mechanism for this diastereoselective cyclization by an intramolecular Mannich reaction is depicted in Scheme 4. First, the iminium ion species formed by the reaction of amine 3 and the corresponding aldehyde adopts the lowestenergy chair-like conformation in which the two hydrogen atoms are in pseudo-axial positions. Then the enamine, formed by L-proline and the ketone, attacks the iminium ion to form Scheme 4. Mechanism for the diastereoselective cyclization reaction.
the final piperidin-4-one with a cis configuration with the two bulky aryl groups in equatorial positions. The cis stereochemistry of the products was confirmed by NOESY studies.
With the core scaffolds 4A-C in hand, we focused on the development of a new library of spiro compounds based on the derivatization of the ketone by the classic Pictet-Spengler reaction.
[14] Initially, 3-methoxy-, 3,4-dimethoxy-and 3-fluorophenethylamine were selected as test substrates (Scheme 5). [15] Scheme 5. Reactions of the piperidin-4-ones 4A-C with 2-phenylethylamines.
Test reactions without catalyst failed to achieve full conversion into the corresponding imines. However, after thorough investigation (see the Supporting Information), the reactions in the presence of Ti(OiPr) 4 showed complete conversion. When performing the subsequent Pictet-Spengler reaction using both TFA and TfOH as promoters, however, no cyclized product was observed in any of the reactions.
Based on these preliminary results, the more reactive tryptamine was chosen as the model starting substrate ( Table 2 ). The reactions of 4A-C with tryptamine were carried out in dichloromethane in the presence of 4 Å molecular sieves, which smoothly afforded the imine intermediate. The addition of TFA at 0°C then led to the diastereoselective formation of compounds 7Aa-Ca in moderate yields ( Table 2 , Method A).
Further screening of the reaction conditions (see Table S7 in the Supporting Information) led us to conclude that optimal conversion into the imine could be achieved by the reaction of the selected amine with Ti(OiPr) 4 (1.3 equiv.) in the presence of Et 3 N (1.2 equiv., only for substrates delivered as the hydrochloride salt) in THF at room temperature. As previously stated, the addition of TFA at 0°C then successfully delivered the desired Pictet-Spengler cyclization products. It is important to note that in all cases initially a mixture of the piperidin-4-one and imine was formed, and full conversion into the imine could not be achieved. By using these conditions, compounds 7Ab-Cd were synthesized in an average yield of 67 %. It is worth noting that TfOH was used as the acid in the synthesis of compounds 7Ad-Cd. In these instances, the use of TFA in different amounts (2.2, 4 .0 and 7.0 equiv.) was not sufficient for the cyclization to take place.
[16] The resulting molecules, which contain three N-H groups, were difficult to purify by standard silica gel column chromatography. For this reason, the products were isolated by inactivation of the silica with Et 3 N. Moreover, after column chromatography, an additional washing step was performed with NH 4 OH (25 % in water) to remove residual triethylammonium salts.
To explain the diastereoselectivity we propose a rationale that is in accordance with the known reactivity of cyclohexan- Table 2 . Scope of the Pictet-Spengler cyclization reaction.
[a] Method A: reaction carried out in CH 2 Cl 2 in the presence of molecular sieves, followed by the addition of TFA. Method B: Ti(OiPr) 4 (1.3 equiv.) in THF followed by the addition of TFA or TfOH. [b] Yield given based on recovered starting material (BORSM) for compounds 7Ab-Cd.
ones towards nucleophiles. [17] The cyclization presumably proceeds through a chair-like transition state in which the indole ring exclusively attacks from the equatorial direction, which is the least hindered side (Scheme 6). 2D NMR studies (NOESY) confirmed the stereochemistry of products 7Aa-Cd.
To extend this library of compounds and to further expand the scope of the synthetic strategy, we synthesized compound 12 from indole-2-carbaldehyde, and compound 13 by using a smaller pyrrole-based heterocycle (Schemes 7 and 8). First, the Pictet-Spengler precursors 9 and 11 were synthesized starting Scheme 6. Rationale for the diastereoselectivity of the Pictet-Spengler cyclization reaction.
from the commercially available indole-2-carbaldehyde and pyrrole-2-carbaldehyde by Henry reactions with nitromethane.
[18] Next, the intermediate nitro alkene 8 was reduced by using LiAlH 4 in Et 2 O for the synthesis of 9, and nitro alkene 10 was reduced with a mixture of NaBH 4 /NiCl 2 to give 11 (Scheme 7).
[19] Scheme 7. Henry reaction and subsequent reduction for the synthesis of amines 9 and 11.
Finally, precursors 9 and 11 were subjected to the previously optimized conditions in the presence of piperidin-4-one 4A to afford the corresponding Pictet-Spengler products 12 and 13 in 52 % yield with complete diastereoselectivity in both cases (Scheme 8).
Scheme 8. Synthesis of spiro compounds 12 and 13.
Conclusions
An enantio-and diastereoselective route for the synthesis of a new class of spirocyclic piperidine structures by means of a Mannich and Pictet-Spengler reaction sequence has been developed. Three new cis-2,6-disubstituted piperidin-4-one analogues containing fluorine functionalities were synthesized and 1 H NMR data are reported as follows: chemical shift (ppm), multiplicity (s = singlet, d = doublet, dd = doublet of doublets, dt = doublet of triplets, ddd = doublet of doublet of doublets, t = triplet, m = multiplet, br. = broad), coupling constants (Hz) and integration. The compounds were fully characterized by 1 H and 13 C NMR spectra and 2D gDQCOSY, gHSQC, gHMBC and NOESY spectra.
(4S)-4-(3,4-Dimethoxyphenyl)-4-[(4-methoxyphenyl)amino]-
butan-2-one (1): 3,4-Dimethoxybenzaldehyde (10.5 g, 63.2 mmol), 4-anisidine (7.78 g, 63.2 mmol) and L-proline (1.5 g, 12.64 mmol) were added to a mixture of DMSO (45 mL) and acetone (180 mL). The resulting reaction mixture was stirred for 23 h. The reaction was then quenched with potassium phosphate buffer (0.5 M, pH 7, 100 mL). Subsequently, potassium phosphate buffer (0.5 M, pH 7, a total of 150 mL) was added in portions. The reaction mixture was cooled to 0°C, and the product started to precipitate. After stirring for 20 min, the suspension was filtered and the residue was washed with water (0°C, 50 mL). The product was dried in vacuo. The product was obtained as an off-white powder (19 g) and recrystallized from EtOAc to give white crystals (12.7 g, 38.5 mmol) . Yield: 61 %. 5, 152.5, 149.3, 148.2, 141.1, 135.5, 118.3, 115.5, 114.8, 111.3, 109.6, 56.0, 55.9, 55.7, 55.3, 51.5, 30.9 ppm. FTIR: ν = 3385, 1708 5, 152.5, 149.3, 148.2, 141.1, 135.5, 118.3, 115.5, 114.8, 111.3, 109.6, 56.0, 55.9, 55.7, 55.3, 51.5, 30.9 ppm. FTIR: ν = 3385, , 1510 5, 152.5, 149.3, 148.2, 141.1, 135.5, 118.3, 115.5, 114.8, 111.3, 109.6, 56.0, 55.9, 55.7, 55.3, 51.5, 30.9 ppm. FTIR: ν = 3385, , 1253 5, 152.5, 149.3, 148.2, 141.1, 135.5, 118.3, 115.5, 114.8, 111.3, 109.6, 56.0, 55.9, 55.7, 55.3, 51.5, 30.9 ppm. FTIR: ν = 3385, , 1235 5, 152.5, 149.3, 148.2, 141.1, 135.5, 118.3, 115.5, 114.8, 111.3, 109.6, 56.0, 55.9, 55.7, 55.3, 51.5, 30.9 ppm. FTIR: ν = 3385, , 1139 5, 152.5, 149.3, 148.2, 141.1, 135.5, 118.3, 115.5, 114.8, 111.3, 109.6, 56.0, 55.9, 55.7, 55.3, 51.5, 30.9 ppm. FTIR: ν = 3385, , 1027 
(3S)-4-(3,4-Dimethoxyphenyl)-4-[(E)-(4-fluorobenzylidene)-amino]butan-2-one (5):
Triethylamine (0.44 mL, 3.18 mmol) and 4-fluorobenzaldehyde (0.34 mL, 3.18 mmol) were added to a solution of 3 (1.65 g, 6.36 mmol) in dry 1,2-dichloroethane (115 mL). The mixture was concentrated in vacuo. Dry 1,2-dichloroethane (110 mL) was added to the residue, and the mixture was concentrated again in vacuo. Dry 1,2-dichloroethane (110 mL) and triethylamine (0.44 mL, 3.18 mmol) were added to the resulting mixture, which was concentrated in vacuo. The mixture was dissolved in dry 1,2-dichloroethane (113 mL), and triethylamine (0.44 mL, 3.18 mmol) and 4-fluorobenzaldehyde (0.03 mL, 0.32 mmol) were added. The resulting mixture was concentrated in vacuo to afford the crude imine. General Procedure for the Synthesis of Compounds 4A-C: A mixture of 3 (1.00 equiv.), triethylamine (1.00 equiv.), the corresponding aldehyde (1.00 equiv.), L-proline (0.20 equiv.) and anhydrous Na 2 SO 4 (0.28 equiv.) in EtOH was stirred at room temperature under an inert gas for 3-4 h. Then the reaction was quenched with NH 4 Cl (75 mL), and the aqueous layer was extracted with EtOAc (3 × 200 mL). The organic layers were combined and extracted with a solution 0.1 M HCl (3 × 200 mL). The combined aqueous layers were washed with EtOAc and neutralized with 1.0 M aqueous sodium hydroxide to pH 7-8. The aqueous layer was extracted with EtOAc (3 × 200 mL), saturated brine solution was added, and the organic layers were dried with anhydrous Na 2 SO 4 , filtered and concentrated under reduced pressure to afford compounds 4A-C.
(2S,6R)-2-(3,4-Dimethoxyphenyl)-6-(4-fluorophenyl)piperidin-4-one (4A): According to the general procedure, the reaction of amino ketone hydrochloride 3 (2.5 g, 9.63 mmol) and 4-fluorobenzaldehyde afforded 4A (2.4 g, 7.28 
General Procedure for the Synthesis of Compounds 7Aa-Ca:
A mixture of piperidin-4-one 4A-C (1.00 equiv.) and tryptamine (1.00 equiv. for the synthesis of 7Aa and 7Ca and 1.60 equiv. for the synthesis of 7Ba) dissolved in CH 2 Cl 2 in the presence of molecular sieves was stirred at 21°C under an inert gas for the time indicated in each case. Then the solution was cooled to 0°C, TFA (2.2 equiv.) was added and the reaction mixture was warmed to 21°C and stirred for the time indicated in each case. The reaction was quenched with a saturated NaHCO 3 solution, and the aqueous layer was extracted with CH 2 Cl 2 (3 ×). The combined organic layers were washed with brine, dried with Na 2 SO 4 , filtered and concentrated in vacuo.
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6-(4-fluorophenyl)-2′,3′,4′,9′-tetrahydrospiro[piperidine-4,1′-pyrido[3,4-b]indole] (7Aa):
According to the general procedure, the reaction mixture of piperidin-4-one 4A (51.5 mg, 0.16 mmol) was stirred in CH 2 Cl 2 (2.5 mL) overnight to form the imine. TFA (27 μL, 0.34 mmol) in CH 2 Cl 2 (0.14 mL) was added, and the mixture was stirred for 48 h. The crude mixture was purified by column chromatography [heptane/EtOAc (4:1) → EtOAc] and ion-exchange column chromatography (ISOLUTE SCX-2) to afford compound 7Aa (38.5 mg, 0.08 mmol) as a yellow solid. Yield: 52 %. R F = 0.43 (EtOAc 
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6-[4-(trifluoromethyl)-phenyl]-2′,3′,4′,9′-tetrahydrospiro[piperidine-4,1′-pyrido[3,4-b]-indole] (7Ba):
According to the general procedure, the reaction mixture of piperidin-4-one 4B (100 mg, 0.26 mmol) was stirred, in the presence of 4 Å molecular sieves, in CH 2 Cl 2 (5 mL) for 5 h to form the imine. TFA (44 μL, 0.57 mmol) in CH 2 Cl 2 (0.25 mL) was added, and the mixture was stirred for 24 h. The crude product was purified by two column chromatographic procedures [heptane/ EtOAc (3:1) → EtOAc/MeOH (10:1) and heptane/EtOAc (2:3) → EtOAc/MeOH (10:1)] to afford compound 7Ba (56.6 mg, 0.11 mmol). Yield: 41 %. R F = 0.22 (heptane/EtOAc, 2:3 
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6-[4-(pentafluoro-λ 6 -sulfanyl)phenyl]-2′,3′,4′,9′-tetrahydrospiro[piperidine-4,1′-pyrido[3,4-b]indole] (7Ca):
According to the general procedure, the reaction mixture of piperidin-4-one 4C (40 mg, 0.09 mmol) was stirred, in the presence of 4 Å molecular sieves, in CH 2 Cl 2 (1.5 mL) for 5 h to form the imine. TFA (20 μL, 0.20 mmol) was added, and the mixture was stirred overnight. The crude product was purified by column chromatography [heptane/EtOAc (4:1) → EtOAc] to afford compound 7Ca (24.4 mg, 0.042 mmol). Yield: 47 %. R F = 0.34 (heptane/EtOAc, 2:3). 149.1, 148.8, 148.4, 139.1, 137.1, 135.6, 127.5, 127.1 (2 ×), 126.3 (quint, J = 4.6 Hz, 2 ×), 122.0, 119.5, 118.9, 118.4, 111.3, 110.9, 110.1, 109.0, 56.3 (2 ×), 56.1, 56.1, 53.2, 45.1, 44.8, 39.4, 23.2 ppm. FTIR: ν = 3373, 2934 , 2838 , 1592 , 1515 , 1232 , 1138 , 1027 
General Procedure for the Synthesis of Compounds 7Ab-Cb:
A solution of Ti(OiPr) 4 (1.30 equiv.) in dry THF (0.5 mL) was added to a mixture of piperidin-4-one 4A-C (1.00 equiv.) and 6-methoxytryptamine (1.20 equiv.) in dry THF (2 mL) at 21°C under argon. After 6 h, TFA (2.20 equiv.) dissolved in dry THF (0.5 mL) was added at 0°C, and the reaction mixture was warmed to 21°C and stirred for 19-24 h. The reaction was quenched with a saturated NaHCO 3 solution and the mixture diluted with EtOAc. The layers were separated, and the aqueous phase was extracted with EtOAc (3 ×). The combined organic layers were washed with brine, dried with Na 2 SO 4 , filtered and concentrated in vacuo. The crude product was purified by column chromatography [heptane/EtOAc (2:1) → EtOAc/MeOH (10:1)]. The dried product was dissolved in CH 2 Cl 2 (5 mL) and washed with aqueous NH 4 OH (5 mL). The aqueous phase was extracted with CH 2 Cl 2 (3 × 5 mL), and the combined organic layers were washed with brine, dried with Na 2 SO 4 , filtered and dried in vacuo to afford compounds 7Ab-Cb. 156.4, 149.1, 148.3, 140.5, 138.2, 137.3, 136.4, 128.4 (d, J = 7.9 Hz, 2 ×), 122.0, 118.9, 118.8, 115.4 (d, J = 21.2 Hz, 2 ×), 111.2, 110.1, 108.9, 108.7, 95.1, 56.6, 56.3, 56.1 (2 ×), 55.9, 53.2, 45.1, 45.0, 39.4, 23.3 ppm. FTIR: ν = 3366, 2931 , 2835 , 1628 , 1507 , 1223 , 1153 , 1025 9, 118.8, 111.3, 110.2, 108.8, 108.7, 95.2, 56.6, 56.4, 56.1 (2 ×), 55.9, 53.2, 45.1, 44.9, 39.4, 23.3 ppm. FTIR: ν = 3369, 2926 9, 118.8, 111.3, 110.2, 108.8, 108.7, 95.2, 56.6, 56.4, 56.1 (2 ×), 55.9, 53.2, 45.1, 44.9, 39.4, 23.3 ppm. FTIR: ν = 3369, , 2835 9, 118.8, 111.3, 110.2, 108.8, 108.7, 95.2, 56.6, 56.4, 56.1 (2 ×), 55.9, 53.2, 45.1, 44.9, 39.4, 23.3 ppm. FTIR: ν = 3369, , 1619 9, 118.8, 111.3, 110.2, 108.8, 108.7, 95.2, 56.6, 56.4, 56.1 (2 ×), 55.9, 53.2, 45.1, 44.9, 39.4, 23.3 ppm. FTIR: ν = 3369, , 1515 9, 118.8, 111.3, 110.2, 108.8, 108.7, 95.2, 56.6, 56.4, 56.1 (2 ×), 55.9, 53.2, 45.1, 44.9, 39.4, 23.3 ppm. FTIR: ν = 3369, , 1260 9, 118.8, 111.3, 110.2, 108.8, 108.7, 95.2, 56.6, 56.4, 56.1 (2 ×), 55.9, 53.2, 45.1, 44.9, 39.4, 23.3 ppm. FTIR: ν = 3369, , 1097 9, 118.8, 111.3, 110.2, 108.8, 108.7, 95.2, 56.6, 56.4, 56.1 (2 ×), 55.9, 53.2, 45.1, 44.9, 39.4, 23.3 ppm. FTIR: ν = 3369, , 1066 . HRMS (ESI): calcd. for [C 31 H 32 According to the general procedure, the reaction of piperidin-4-one 4C (50 mg, 0.114 mmol) afforded 7Cb (18.1 mg, 0.030 mmol). In this case, after applying the general procedure, the crude product was purified by a second column chromatography [heptane/EtOAc (2:1) → EtOAc/MeOH (10:1)] and ion-exchange column chromatography (ISOLUTE SCX-2). The dried product was dissolved again in CH 2 Cl 2 (5 mL) and washed with aqueous NH 4 OH (5 mL). The combined aqueous layers were extracted with CH 2 Cl 2 (3 × 5 mL), and the organic layers were washed with brine, dried with Na 2 SO 4 , filtered and dried in vacuo. 122.0, 118.9, 118.9, 111.3, 110.1, 108.9, 108.8, 95.2, 56.3 (2 ×), 56.1, 56.1, 55.9, 53.2, 45.1, 44.8, 39.4, 23.3 ppm. FTIR: ν = 3371, 2938 122.0, 118.9, 118.9, 111.3, 110.1, 108.9, 108.8, 95.2, 56.3 (2 ×), 56.1, 56.1, 55.9, 53.2, 45.1, 44.8, 39.4, 23.3 ppm. FTIR: ν = 3371, , 2837 122.0, 118.9, 118.9, 111.3, 110.1, 108.9, 108.8, 95.2, 56.3 (2 ×), 56.1, 56.1, 55.9, 53.2, 45.1, 44.8, 39.4, 23.3 ppm. FTIR: ν = 3371, , 1629 122.0, 118.9, 118.9, 111.3, 110.1, 108.9, 108.8, 95.2, 56.3 (2 ×), 56.1, 56.1, 55.9, 53.2, 45.1, 44.8, 39.4, 23.3 ppm. FTIR: ν = 3371, , 1516 122.0, 118.9, 118.9, 111.3, 110.1, 108.9, 108.8, 95.2, 56.3 (2 ×), 56.1, 56.1, 55.9, 53.2, 45.1, 44.8, 39.4, 23.3 ppm. FTIR: ν = 3371, , 1262 122.0, 118.9, 118.9, 111.3, 110.1, 108.9, 108.8, 95.2, 56.3 (2 ×), 56.1, 56.1, 55.9, 53.2, 45.1, 44.8, 39.4, 23.3 ppm. FTIR: ν = 3371, , 1154 122.0, 118.9, 118.9, 111.3, 110.1, 108.9, 108.8, 95.2, 56.3 (2 ×), 56.1, 56.1, 55.9, 53.2, 45.1, 44.8, 39.4, 23.3 ppm. FTIR: ν = 3371, , 1027 and Ti(OiPr) 4 (58 μL, 0.197 mmol) dissolved in dry THF (0.25 mL) were added to a mixture of 4A (50 mg, 0.152 mmol) and 5-hydroxytryptamine hydrochloride (38.7 mg, 0.182 mmol) dissolved in dry THF (0.5 mL). After 30 min, additional Et 3 N (25 μL, 0.182 mmol) and THF (16.5 mL) were added. After 4.5 h, TFA (52 μL, 0.668 mmol) dissolved in dry THF (0.5 mL) was added at 0°C, and the reaction mixture was warmed to 21°C and stirred for 21 h. The reaction was quenched with an aqueous saturated NaHCO 3 solution and the mixture diluted with EtOAc. The organic and aqueous phases were separated, and the aqueous phase was extracted with EtOAc (4 ×).
(2S,4S,6R)-2-(3,4-Dimethoxyphenyl)-6-(4-fluorophenyl)-7′-meth
The combined organic layers were washed with brine, dried with Na 2 SO 4 , filtered and dried in vacuo. The crude product was dissolved in dry THF (2 mL), and 5-hydroxytryptamine hydrochloride (15.5 mg, 0.073 mmol), Et 3 N (10 μL, 0.073 mmol) in dry THF (0.5 mL) and Ti(OiPr) 4 (23.2 μL, 0.079 mmol) were added. After 3 h, TFA (10.4 μL, 0.134 mmol) was added at 0°C, and the reaction mixture was warmed to 21°C and stirred for 20.5 h. The reaction was quenched with an aqueous saturated NaHCO 3 solution and diluted with EtOAc. The organic and aqueous phases were separated, and the aqueous phase was extracted with EtOAc (4 ×). The combined organic layers were washed with brine, dried with Na 2 SO 4 , filtered and dried in vacuo. The crude product was purified by column chromatography [EtOAc → EtOAc/MeOH (10:1)]. The dried product was dissolved in CH 2 Cl 2 (5 mL) and washed with aqueous NH 4 OH (2 × 5 mL). The combined aqueous layers were extracted with CH 2 Cl 2 (3 × 10 mL), and the combined organic layers were washed with brine, dried with Na 2 SO 4 , filtered and dried in vacuo to afford 7Ac 2 Hz), 149.6, 149.1, 148.4, 140.6, 140.2 (d, J = 2.9 Hz), 137.1, 130.9, 128.5 (d, J = 7.9 Hz, 2 ×), 128.3, 119.0, 115.4 (d, J = 21.2 Hz, 2 ×), 111.5, 111.5, 111.3, 110.2, 108.4, 103.4, 56.7, 56.4, 56.1, 56.1, 53.4, 44.8 (2 ×), 39.3, 23.2 ppm. FTIR: ν = 3367, 2931 , 2838 , 1591 , 1515 , 1261 , 1118 , 1016 4 (50 μL, 0.171 mmol) dissolved in dry THF (0.50 mL) were added to a mixture of 4B (50 mg, 0.132 mmol) and 5-hydroxytryptamine hydrochloride (33.6 mg, 0.158 mmol) dissolved in dry THF (2 mL). After 7 h, TFA (22 μL, 0.290 mmol) dissolved in dry THF (0.5 mL) was added at 0°C, and the reaction mixture was warmed to 21°C and stirred for 23 h. The reaction was quenched with an aqueous saturated NaHCO 3 solution and the mixture diluted with EtOAc. The organic and aqueous phases were separated, and the aqueous phase was extracted with EtOAc (4 h). The combined organic layers were washed with brine, dried with Na 2 SO 4 , filtered and dried in vacuo. The crude product was dissolved in dry THF (1.5 mL), and 5-hydroxytryptamine hydrochloride (33.6 mg, 0.158 mmol), Et 3 N (22 μL, 0.158 mmol) in dry THF (0.5 mL) and Ti(OiPr) 4 (50 μL, 0.171 mmol) were added. After 7 h, TFA (22 μL, 0.290 mmol) dissolved in dry THF (0.5 mL) was added at 0°C, and the reaction mixture was warmed to 21°C and stirred for 24.5 h.
The reaction was quenched with an aqueous saturated NaHCO 3 solution and diluted with EtOAc. The organic and aqueous phases were separated, and the aqueous phase was extracted with EtOAc (3 ×). The combined organic layers were washed with brine, dried with Na 2 SO 4 , filtered and dried in vacuo. The crude product was purified by column chromatography [heptane/EtOAc (1:1) → EtOAc/ MeOH (10:1)]. The dried product was dissolved in CH 2 Cl 2 (5 mL) and washed with aqueous NH 4 OH (5 mL). The aqueous layer was extracted with CH 2 Cl 2 (3 × 5 mL), and the combined organic layers were washed with brine, dried with Na 2 SO 4 , filtered and dried in vacuo to afford 7Bc ( 6, 149.1, 148.5, 148.3, 140.3, 136.7, 130.9, 129 .6 (q, J = 32.4 Hz), 128.2, 127.3 (2 ×), 125.6 (q, J = 3.7 Hz, 2 ×), 124.3 (q, J = 272.0 Hz, CF 3 ), 119.1, 111.7, 111.5, 111.3, 110.2, 108.3, 103.5, 56.7, 56.6, 56.1, 56.0, 53.4, 44.5, 44.3, 39.3, 23.1 ppm. FTIR: ν = 3364, 3305, 2931 119.1, 111.7, 111.5, 111.3, 110.2, 108.3, 103.5, 56.7, 56.6, 56.1, 56.0, 53.4, 44.5, 44.3, 39.3, 23.1 ppm. FTIR: ν = 3364, 3305, , 2836 119.1, 111.7, 111.5, 111.3, 110.2, 108.3, 103.5, 56.7, 56.6, 56.1, 56.0, 53.4, 44.5, 44.3, 39.3, 23.1 ppm. FTIR: ν = 3364, 3305, , 1591 119.1, 111.7, 111.5, 111.3, 110.2, 108.3, 103.5, 56.7, 56.6, 56.1, 56.0, 53.4, 44.5, 44.3, 39.3, 23.1 ppm. FTIR: ν = 3364, 3305, , 1509 119.1, 111.7, 111.5, 111.3, 110.2, 108.3, 103.5, 56.7, 56.6, 56.1, 56.0, 53.4, 44.5, 44.3, 39.3, 23.1 ppm. FTIR: ν = 3364, 3305, , 1223 119.1, 111.7, 111.5, 111.3, 110.2, 108.3, 103.5, 56.7, 56.6, 56.1, 56.0, 53.4, 44.5, 44.3, 39.3, 23.1 ppm. FTIR: ν = 3364, 3305, , 1140 119.1, 111.7, 111.5, 111.3, 110.2, 108.3, 103.5, 56.7, 56.6, 56.1, 56.0, 53.4, 44.5, 44.3, 39.3, 23.1 ppm. FTIR: ν = 3364, 3305, , 1024 and 5-hydroxytryptamine hydrochloride (29.2 mg, 0.137 mmol) in dry THF (2 mL). After 6 h, TFA (19 μL, 0.251 mmol) dissolved in dry THF (0.5 mL) was added at 0°C, and the reaction mixture was warmed to 21°C and stirred for 20 h. The reaction was quenched with NaHCO 3 and the mixture diluted with EtOAc. The organic layer was separated, and the aqueous phase was extracted with EtOAc (4 ×). The combined organic layers were washed with brine, dried with Na 2 SO 4 , filtered and dried in vacuo. The crude product was purified by column chromatography [heptane/EtOAc (1:1) → EtOAc/ MeOH (10:1)], and the dried product was dissolved in CH 2 Cl 2 (5 mL) and washed with aqueous NH 4 OH (5 mL). The aqueous phase was extracted with CH 2 Cl 2 (3 × 5 mL), and the combined organic layers were washed with brine, dried with Na 2 SO 4 , filtered and dried in vacuo to afford 7Cc (32.4 mg, 0.054 mmol) as a purple solid. Yield 9 Hz), 149.6, 149.2, 148.5, 148.3, 140.2, 136.7, 130.9, 128.2, 127.2 (2 ×), 126.3 (quint, J = 4.2 Hz, 2 ×), 119.1, 111.7, 111.5, 111.3, 110.2, 108.4, 103.5, 56.5, 56.4, 56.1, 56.1, 53.3, 44.6, 44.3, 39.3, 23.1 ppm. FTIR: ν = 3367, 2961 , 2839 , 1592 , 1516 , 1260 
General Procedure for the Synthesis of Compounds 7Ad-Cd:
A solution of Et 3 N (1.20 equiv.) in dry THF (0.5 mL) and a solution of Ti(OiPr) 4 (1.30 equiv.) in dry THF (0.5 mL) were added to a mixture of piperidin-4-one 4A-C (1.00 equiv.) and 5-fluorotryptamine hydrochloride (1.20 equiv.) in dry THF (2 mL) at 21°C under argon. After 4-7 h, TfOH (3.00 equiv. for 7Ad and 7Bd and 3.50 equiv. for 7Cd) dissolved in dry THF (0.5 mL) was added at 0°C, and the reaction mixture was warmed to 21°C and stirred for 22-25 h. The reaction was quenched with a saturated NaHCO 3 solution and the mixture diluted with EtOAc. The layers were separated, and the aqueous phase was extracted with EtOAc (3 ×). The combined organic layers were washed with brine, dried with Na 2 SO 4 , filtered and concentrated in vacuo. The crude product was purified by column chromatography [heptane/EtOAc (2:1) → EtOAc/MeOH (10:1)], and the dried product was dissolved in CH 2 Cl 2 (5 mL) and washed with aqueous NH 4 OH (5 mL). The aqueous phase was extracted with CH 2 Cl 2 (3 × 5 mL), and the combined organic layers were washed with brine, dried with Na 2 SO 4 , filtered and dried in vacuo to afford compounds 7Ad-Cd. According to the general procedure, the reaction of piperidin-4-one 4B (50 mg, 0.132 mmol) afforded 7Bd (21.9 mg, 0.041 mmol) as a yellow solid. In this case, after applying the general procedure, the crude product was purified for a second time by ion-exchange column chromatography (ISOLUTE SCX-2). The dried product was dissolved in CH 2 Cl 2 (5 mL) and washed with aqueous NH 4 OH (5 mL). The aqueous phase was extracted with CH 2 Cl 2 (3 × 5 mL), and the combined organic layers were washed with brine, dried with Na 2 SO 4 , filtered and dried in vacuo. Yield 2 Hz), 56.6, 56.5, 56.1, 56.1, 53.2, 44.6, 44.4, 39.3, 23.1 ppm. FTIR: ν = 3362, 2935 , 2837 , 1586 , 1514 , 1261 , 1017 . HRMS (ESI): calcd. for [C 30 H 29 Supporting Information (see footnote on the first page of this article): Full experimental details for the preparation of the compounds described herein, characterization of new compounds and 1 H and 13 C NMR spectra.
